Type 2 diabetes mellitus with other specified complication
ICD-10 E11.69 is a billable code used to indicate a diagnosis of type 2 diabetes mellitus with other specified complication.
E11.69 refers to Type 2 diabetes mellitus with other specified complications that are not classified under more specific codes. Type 2 diabetes is characterized by insulin resistance and relative insulin deficiency, leading to chronic hyperglycemia. Patients may experience a range of complications, including neuropathy, retinopathy, nephropathy, and cardiovascular diseases. The 'other specified complication' designation allows for the inclusion of complications that do not fit neatly into established categories, such as skin infections, gastrointestinal issues, or other metabolic disturbances. Management of Type 2 diabetes often involves lifestyle modifications, oral hypoglycemic agents, and sometimes insulin therapy, depending on the severity of the disease and the patient's response to treatment. Regular monitoring of HbA1c levels is crucial for assessing long-term glycemic control, with targets typically set below 7% for most adults. The complexity of coding E11.69 arises from the need for precise documentation of the specific complications present, as well as the potential for overlapping conditions that may require careful differentiation.
Detailed patient history, including HbA1c levels, treatment plans, and specific complications.
Patients presenting with uncontrolled blood sugar levels and associated complications.
Endocrinologists must ensure that all complications are documented clearly to support the use of E11.69.
Comprehensive records of patient visits, including lifestyle modifications and medication adjustments.
Routine follow-ups for diabetes management and monitoring of complications.
Primary care providers should document all relevant patient education and management strategies to justify coding.
Used for follow-up visits for diabetes management.
Document the patient's diabetes management plan and any complications.
Endocrinologists may require more detailed documentation compared to primary care.
Common complications include neuropathy, retinopathy, nephropathy, cardiovascular diseases, and skin infections. Each of these may require specific documentation and coding.
HbA1c levels should typically be monitored every 3 to 6 months, depending on the patient's treatment plan and stability of their blood glucose levels.